Proactiveinvestors USA & Canada TRACON Pharmaceuticals https://www.proactiveinvestors.com Proactiveinvestors USA & Canada TRACON Pharmaceuticals RSS feed en Sat, 30 May 2020 11:35:41 -0400 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) TRACON Pharmaceuticals says separate study buoys potential of envafolimab combination to treat sarcoma https://www.proactiveinvestors.com/companies/news/920734/tracon-pharmaceuticals-says-separate-study-buoys-potential-of-envafolimab-combination-to-treat-sarcoma-920734.html Fri, 29 May 2020 13:40:00 -0400 https://www.proactiveinvestors.com/companies/news/920734/tracon-pharmaceuticals-says-separate-study-buoys-potential-of-envafolimab-combination-to-treat-sarcoma-920734.html TRACON Pharmaceuticals looks forward to positive Phase 2 cancer trial data presentation on May 31 https://www.proactiveinvestors.com/companies/news/919635/tracon-pharmaceuticals-looks-forward-to-positive-phase-2-cancer-trial-data-presentation-on-may-31-919635.html Thu, 14 May 2020 17:10:00 -0400 https://www.proactiveinvestors.com/companies/news/919635/tracon-pharmaceuticals-looks-forward-to-positive-phase-2-cancer-trial-data-presentation-on-may-31-919635.html TRACON Pharmaceuticals to see envafolimab cancer treatment data presented at virtual oncology conference https://www.proactiveinvestors.com/companies/news/919630/tracon-pharmaceuticals-to-see-envafolimab-cancer-treatment-data-presented-at-virtual-oncology-conference-919630.html Thu, 14 May 2020 15:01:00 -0400 https://www.proactiveinvestors.com/companies/news/919630/tracon-pharmaceuticals-to-see-envafolimab-cancer-treatment-data-presented-at-virtual-oncology-conference-919630.html TRACON Pharmaceuticals believes its ENVASARC trial on envafolimab will enable a quick path to market https://www.proactiveinvestors.com/companies/news/919523/tracon-pharmaceuticals-believes-its-envasarc-trial-on-envafolimab-will-enable-a-quick-path-to-market-919523.html Wed, 13 May 2020 21:00:00 -0400 https://www.proactiveinvestors.com/companies/news/919523/tracon-pharmaceuticals-believes-its-envasarc-trial-on-envafolimab-will-enable-a-quick-path-to-market-919523.html TRACON Pharmaceuticals 'very pleased' with envafolimab pre-IND meeting with FDA https://www.proactiveinvestors.com/companies/news/919310/tracon-pharmaceuticals--very-pleased--with-envafolimab-pre-ind-meeting-with-fda-919310.html Mon, 11 May 2020 18:20:00 -0400 https://www.proactiveinvestors.com/companies/news/919310/tracon-pharmaceuticals--very-pleased--with-envafolimab-pre-ind-meeting-with-fda-919310.html TRACON Pharmaceuticals announces successful Type B meeting with FDA for Pivotal Study of Envafolimab in sarcoma https://www.proactiveinvestors.com/companies/news/919284/tracon-pharmaceuticals-announces-successful-type-b-meeting-with-fda-for-pivotal-study-of-envafolimab-in-sarcoma-919284.html Mon, 11 May 2020 14:25:00 -0400 https://www.proactiveinvestors.com/companies/news/919284/tracon-pharmaceuticals-announces-successful-type-b-meeting-with-fda-for-pivotal-study-of-envafolimab-in-sarcoma-919284.html TRACON Pharmaceuticals retains rights to prostate cancer drug candidate, targets China for commercialization https://www.proactiveinvestors.com/companies/news/918087/tracon-pharmaceuticals-retains-rights-to-prostate-cancer-drug-candidate-targets-china-for-commercialization-918087.html Fri, 24 Apr 2020 13:30:00 -0400 https://www.proactiveinvestors.com/companies/news/918087/tracon-pharmaceuticals-retains-rights-to-prostate-cancer-drug-candidate-targets-china-for-commercialization-918087.html TRACON Pharmaceuticals names Shahe Garabedian as senior vice president of quality assurance https://www.proactiveinvestors.com/companies/news/917211/tracon-pharmaceuticals-names-shahe-garabedian-as-senior-vice-president-of-quality-assurance-917211.html Tue, 14 Apr 2020 14:50:00 -0400 https://www.proactiveinvestors.com/companies/news/917211/tracon-pharmaceuticals-names-shahe-garabedian-as-senior-vice-president-of-quality-assurance-917211.html TRACON earns May 8 date with FDA to discuss pivotal study of its drug envafolimab as a treatment for tissue cancer https://www.proactiveinvestors.com/companies/news/916713/tracon-earns-may-8-date-with-fda-to-discuss-pivotal-study-of-its-drug-envafolimab-as-a-treatment-for-tissue-cancer-916713.html Mon, 06 Apr 2020 13:10:00 -0400 https://www.proactiveinvestors.com/companies/news/916713/tracon-earns-may-8-date-with-fda-to-discuss-pivotal-study-of-its-drug-envafolimab-as-a-treatment-for-tissue-cancer-916713.html TRACON Pharmaceuticals brings on biotech veteran to its board of directors https://www.proactiveinvestors.com/companies/news/915357/tracon-pharmaceuticals-brings-on-biotech-veteran-to-its-board-of-directors-915357.html Thu, 19 Mar 2020 17:52:00 -0400 https://www.proactiveinvestors.com/companies/news/915357/tracon-pharmaceuticals-brings-on-biotech-veteran-to-its-board-of-directors-915357.html TRACON Pharmaceuticals bolsters its board with appointment of Saundra Pelletier as a director https://www.proactiveinvestors.com/companies/news/915332/tracon-pharmaceuticals-bolsters-its-board-with-appointment-of-saundra-pelletier-as-a-director-915332.html Thu, 19 Mar 2020 15:05:00 -0400 https://www.proactiveinvestors.com/companies/news/915332/tracon-pharmaceuticals-bolsters-its-board-with-appointment-of-saundra-pelletier-as-a-director-915332.html TRACON Pharmaceuticals driving the development of targeted therapies for cancer https://www.proactiveinvestors.com/companies/news/915153/tracon-pharmaceuticals-driving-the-development-of-targeted-therapies-for-cancer-915153.html Wed, 18 Mar 2020 12:00:00 -0400 https://www.proactiveinvestors.com/companies/news/915153/tracon-pharmaceuticals-driving-the-development-of-targeted-therapies-for-cancer-915153.html TRACON Pharmaceuticals requests FDA meeting to discuss pivotal study design for Envafolimab to treat sarcoma https://www.proactiveinvestors.com/companies/news/915028/tracon-pharmaceuticals-requests-fda-meeting-to-discuss-pivotal-study-design-for-envafolimab-to-treat-sarcoma-915028.html Mon, 16 Mar 2020 13:25:00 -0400 https://www.proactiveinvestors.com/companies/news/915028/tracon-pharmaceuticals-requests-fda-meeting-to-discuss-pivotal-study-design-for-envafolimab-to-treat-sarcoma-915028.html TRACON Pharmaceuticals and Santen halt development of DE-122 for wet age-related macular degeneration https://www.proactiveinvestors.com/companies/news/914645/tracon-pharmaceuticals-and-santen-halt-development-of-de-122-for-wet-age-related-macular-degeneration-914645.html Tue, 10 Mar 2020 11:51:00 -0400 https://www.proactiveinvestors.com/companies/news/914645/tracon-pharmaceuticals-and-santen-halt-development-of-de-122-for-wet-age-related-macular-degeneration-914645.html TRACON Pharmaceuticals reveals its low-cost drug development efforts in its 4Q and FY results https://www.proactiveinvestors.com/companies/news/913993/tracon-pharmaceuticals-reveals-its-low-cost-drug-development-efforts-in-its-4q-and-fy-results-913993.html Fri, 28 Feb 2020 18:51:00 -0500 https://www.proactiveinvestors.com/companies/news/913993/tracon-pharmaceuticals-reveals-its-low-cost-drug-development-efforts-in-its-4q-and-fy-results-913993.html TRACON Pharmaceuticals advancing development of envafolimab to treat soft tissue sarcoma https://www.proactiveinvestors.com/companies/news/913893/tracon-pharmaceuticals-advancing-development-of-envafolimab-to-treat-soft-tissue-sarcoma-913893.html Thu, 27 Feb 2020 21:41:00 -0500 https://www.proactiveinvestors.com/companies/news/913893/tracon-pharmaceuticals-advancing-development-of-envafolimab-to-treat-soft-tissue-sarcoma-913893.html TRACON Pharmaceuticals reveals platform milestones and most recent pipeline update https://www.proactiveinvestors.com/companies/news/912899/tracon-pharmaceuticals-reveals-platform-milestones-and-most-recent-pipeline-update-912899.html Thu, 13 Feb 2020 15:50:00 -0500 https://www.proactiveinvestors.com/companies/news/912899/tracon-pharmaceuticals-reveals-platform-milestones-and-most-recent-pipeline-update-912899.html Tracon Pharmaceuticals refills pipeline with newly licensed immune checkpoint inhibitor therapy https://www.proactiveinvestors.com/companies/news/910779/tracon-pharmaceuticals-refills-pipeline-with-newly-licensed-immune-checkpoint-inhibitor-therapy-910779.html Thu, 16 Jan 2020 01:22:00 -0500 https://www.proactiveinvestors.com/companies/news/910779/tracon-pharmaceuticals-refills-pipeline-with-newly-licensed-immune-checkpoint-inhibitor-therapy-910779.html TRACON Pharmaceuticals to release important data points on its wet AMD therapy in first half of 2020 https://www.proactiveinvestors.com/companies/news/904871/tracon-pharmaceuticals-to-release-important-data-points-on-its-wet-amd-therapy-in-first-half-of-2020-904871.html Tue, 15 Oct 2019 14:02:00 -0400 https://www.proactiveinvestors.com/companies/news/904871/tracon-pharmaceuticals-to-release-important-data-points-on-its-wet-amd-therapy-in-first-half-of-2020-904871.html TRACON gets US$5mln and licensing deal from Janssen https://www.proactiveinvestors.com/companies/news/166629/tracon-gets-us5mln-and-licensing-deal-from-janssen-166629.html Wed, 28 Sep 2016 14:22:00 -0400 https://www.proactiveinvestors.com/companies/news/166629/tracon-gets-us5mln-and-licensing-deal-from-janssen-166629.html